FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

AbdulRahman Al-Musa

Research Profile

Geographic Areas

Saudi Arabia

Disorders

Procedures

Concepts & Ideas

Retrospective Studies

Living Beings

Infants

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Asim F Belgaumi; Asem Bukhari; Khawar S Siddiqui; Ali Al-Ahmari; AbdulRahman Al-Musa; Amal Al-Seraihy; Mouhab Ayas; Hassan El-Solh
Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children.
Abdallah Al-Nasser; Hassan El-Solh; Edward De Vol; Ibrahim El-Hassan; Ali S Alzahrani; Reem Al-Sudairy; Mohamad Al-Mahr; AbdulRahman Al-Musa; Abdullah Al-Jefri; Mahasen Saleh; Samira Rifai; Asim F Belgaumi; Layla Osman; Khairy Ashraf; Mohammed Salim; Ameurfina Silo; George Roberts
Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience.
Mouhab Ayas; AbdulRahman Al-Musa; Abdullah Al-Jefri; Amal Al-Seraihi; Mohamad Al-Mahr; Samira Rifai; Hassan El-Solh
Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of AbdulRahman Al-Musa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Asim F Belgaumi; Asem Bukhari; Khawar S Siddiqui; Ali Al-Ahmari; AbdulRahman Al-Musa; Amal Al-Seraihy; Mouhab Ayas; Hassan El-Solh
Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children.
Leukemia & lymphoma 2013;54(3):547-54.
2008: Abdallah Al-Nasser; Hassan El-Solh; Edward De Vol; Ibrahim El-Hassan; Ali S Alzahrani; Reem Al-Sudairy; Mohamad Al-Mahr; AbdulRahman Al-Musa; Abdullah Al-Jefri; Mahasen Saleh; Samira Rifai; Asim F Belgaumi; Layla Osman; Khairy Ashraf; Mohammed Salim; Ameurfina Silo; George Roberts
Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience.
Annals of Saudi medicine 2008;28(4):251-9.
2007: Mouhab Ayas; AbdulRahman Al-Musa; Abdullah Al-Jefri; Amal Al-Seraihi; Mohamad Al-Mahr; Samira Rifai; Hassan El-Solh
Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.
Pediatric blood & cancer 2007;49(1):103-4.
2003: Asim F Belgaumi; Mohammed Al-Bakrah; Mohamad Al-Mahr; Abdullah Al-Jefri; AbdulRahman Al-Musa; Mahasen Saleh; Mohammed F Salim; Mohammed Osman; Layla Osman; Hassan El-Solh
Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
Cancer 2003;97(11):2898-903.
2000: R Derek Jenkin; Mohammed Al-Shabanah; Abdulaziz Al-Nasser; Hassan El-Solh; R Aur; R Al Sudairy; MM Mustafa; Ibrahim Al-Fawaz; Alan Gray; M da Cunha; Mouhab Ayas; Mohamad Al-Mahr; Amani Kofide; A N Mahgoub; Samira Rifai; Asim F Belgaumi; Abdullah Al-Jefri; AbdulRahman Al-Musa; Rajeh Sabbah
Extramedullary myeloid tumors in children: the limited value of local treatment.
Journal of pediatric hematology/oncology 2000;22(1):34-40.